-
Univ. Spin-Off Develops Lower Cost 3-D Metal Printing
A spin-off enterprise from University at Buffalo engineering school developed a machine that produces lower-cost aluminum parts with three-dimensional liquid metal printing.
-
Wearable Health Devices Offer Early Disease Detection
An analysis of data from mobile fitness and health tracking devices shows the devices can yield useful results for monitoring a person’s health, including early alerts to the onset of some diseases.
-
Electronic Gene Editing Corrects Inherited Blood Disorder
A team at National Institutes of Health used an electronic-aided process to carry out a gene editing technique that in lab mice repaired a genetic defect causing a rare blood disease.
-
RNA-Nanoparticle Spray Protects Against Plant Viruses
Plant scientists combined synthetic genetic material with clay nanoparticles, which when sprayed on plants provides enduring protection against viruses.
-
MD Anderson, Investment Firm Create Cancer Start-Up
MD Anderson Cancer Center and health care investment enterprise Deerfield Management are starting a new company to develop treatments for cancer that tackle processes feeding tumor growth.
-
Wearable Device Senses Environment for Sight Impaired
A research lab in Finland designed a wearable device using radar to help people with impaired sight sense other people and objects when outdoors.
-
Scripps, Pfizer Collaborate on DNA-Coded Drug Discovery
Drug maker Pfizer Inc. is gaining access to advances in a synthetic chemistry technology developed by Scripps Research Institute that tags compounds with DNA identifiers.
-
Neurology Drug Signals Shown to Help Tooth Repair
Chemical signals from a drug designed to treat Alzheimer’s disease and other neurological disorders were shown in tests with mice to stimulate stem cells that repair teeth.
-
Illumina Partnering with IBM, Phillips on Genomics Tools
Genomics technology company Illumina Inc. is collaborating with technology enterprises IBM and Royal Phillips to expand its sequencing services in precision medicine for cancer.
-
Sanofi Licensing Antibody for Autoimmune Diseases
The global drug company Sanofi is licensing a synthetic antibody to treat autoimmune disorders being developed by a spin-off enterprise from Dartmouth College.